A new weight loss drug could become the best-selling drug of all time. Who can afford it?
A phase 3 clinical trial found a high dose of tirzepatide helped patients lose 22.5% of their body weight on average, or about 52 pounds, better than any medication currently on the market. A “fair” price for tirzepatide could be around $13,000 annually
In 2023, the FDA will likely approve Eli Lilly’s diabetes drug tirzepatide for weight loss — but there’s little indication insurers will widely cover the medication.